普利制药与宁丹新药签署创新药临床研究阶段CMO合作协议

Group 1 - Zhejiang Puli Pharmaceutical Co., Ltd. (referred to as "Puli Pharmaceutical") has signed a cooperation agreement with Nanjing Ningdan New Drug Technology Co., Ltd. (referred to as "Ningdan New Drug") for the contract manufacturing of a certain innovative drug in the clinical research stage [1] - Puli Pharmaceutical will act as the CMO service provider for the innovative drug project, leveraging its mature international high-end manufacturing platform to provide production services [1] - Ningdan New Drug focuses on the research and industrialization of new drugs for central nervous system (CNS) diseases and possesses a comprehensive new drug research and development platform and independent R&D capabilities [1]